chartexchange

CytoSorbents Reports Third Quarter 2026 Financial Results, Achieves Operating Cash Flow Breakeven, and Provides Business and Regulatory Update

PR Newswire | Nov 12, 2026 5:16 PM EST

Delivering on the First of Four Distinct Value Drivers PRINCETON, N.J., Nov. 12, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported...

Read original article